Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07644247
PHASE4

STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump

Sponsor: China National Center for Cardiovascular Diseases

View on ClinicalTrials.gov

Summary

This multi-center, prospective, randomized, double-blinded, placebo-controlled study aims to investigate whether withdrawal of aspirin from the antithrombotic regimen in patients supported with the CH-VAD pump is non-inferior to the standard antithrombotic regimen of vitamin K antagonist combined with aspirin in terms of safety and efficacy.

Official title: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD Pump (STAR Trial)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

370

Start Date

2026-06-25

Completion Date

2029-12-31

Last Updated

2026-06-12

Healthy Volunteers

No

Interventions

DRUG

Warfarin (INR 2-3) with placebo

Warfarin (INR 2-3) with placebo

DRUG

Warfarin (INR 2-3) with aspirin

Warfarin (INR 2-3) with aspirin